Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy-Reference-Cited by-同舟云学术

Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy

Published:2024-02-28 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Gopal Dhanushya,Muthuraj Rajesh,Balaya Rex Devasahayam Arokia,Kanekar Saptami,Ahmed Iqrar,Chandrasekaran Jaikanth^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11030-024-10819-7.pdf

Reference35 articles.

1. Lipinski C, Hopkins A (2004) Navigating chemical space for biology and medicine. Insight Rev Articles 432:855–861. https://doi.org/10.1038/nature03193

2. Pushpakom S, Iorio F, Eyers PA et al (2018) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41–58. https://doi.org/10.1038/nrd.2018.168

3. Bender A, Glen RC (2004) Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2:3204–3218. https://doi.org/10.1039/B409813G

4. Melnikova I, Golden J (2004) Targeting protein kinases. Nat Rev Drug Discov 3:993–994. https://doi.org/10.1038/nrd1600

5. Gavrin LK, Saiah E (2013) Approaches to discover non-ATP site kinase inhibitors. Med Chem Comm 4:41–51. https://doi.org/10.1039/C2MD20180A

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico screening of Fyn kinase inhibitors using classification-based QSAR model, molecular docking, molecular dynamics and ADME study;Molecular Diversity;2024-06-17